Rosa Dimas, Zablah Roberto Arturo, Vazquez-Frias Rodrigo
Grupo de Investigación del Caribe y Centroamérica para la Microbiota, Probióticos y Prebióticos, GICCAMPP, la Romana, Dominican Republic.
Servicio de Gastroenterología y Endoscopia Digestiva, Hospital de Niños "Benjamín Bloom", San Salvador, El Salvador.
Front Pediatr. 2024 Feb 16;11:1283389. doi: 10.3389/fped.2023.1283389. eCollection 2023.
"Disorders of Gut-Brain Interaction (DGBIs)," formerly referred to as "Functional Gastrointestinal Disorders (FGIDs)," encompass a prevalent array of chronic or recurring gastrointestinal symptoms that notably impact the quality of life for affected children and their families. Recent studies have elucidated the intricate pathophysiology of DGBIs, underscoring their correlation with gut microbiota. This review seeks to explore the present comprehension of the gut microbiota's role in DGBI development. While other factors can contribute to DGBIs, the gut microbiota prominently influences the onset and progression of these conditions. According to the Rome IV diagnostic criteria, DGBI prevalence is approximately 40% worldwide. The Rome Foundation has diligently worked for nearly three decades to refine our comprehension of DGBIs. By centering on the gut microbiota, this review sheds light on potential therapeutic interventions for DGBIs, potentially enhancing the quality of life for pediatric patients and their families.
“肠-脑互动障碍(DGBIs)”,以前被称为“功能性胃肠疾病(FGIDs)”,包括一系列常见的慢性或复发性胃肠道症状,这些症状对受影响儿童及其家庭的生活质量有显著影响。最近的研究阐明了DGBIs复杂的病理生理学,强调了它们与肠道微生物群的相关性。本综述旨在探讨目前对肠道微生物群在DGBI发展中作用的理解。虽然其他因素也可能导致DGBIs,但肠道微生物群对这些疾病的发生和发展有显著影响。根据罗马IV诊断标准,全球DGBI患病率约为40%。罗马基金会近三十年来一直在努力完善我们对DGBIs的理解。通过关注肠道微生物群,本综述揭示了DGBIs潜在的治疗干预措施,有可能提高儿科患者及其家庭的生活质量。